| Human |
hsa_circ_ASH1L |
- |
hsa_circRNA_100352 |
myelodysplastic syndrome |
ASH1L |
hsa‐miR‐627‐3p, hsa‐miR‐329‐5p, hsa‐miR‐25‐3p, hsa‐miR‐766‐5p, hsa‐miR‐143‐5p |
Q
M
| UP |
More |
| Human |
hsa_circ_ASH1L |
- |
circASH1L |
bile duct cancer |
ASH1L |
- |
S
| UP |
More |
| Human |
hsa_circ_ASH1L |
- |
circASH1L |
cholangiocarcinoma |
ASH1L |
- |
S
| UP |
More |
| Human |
hsa_circ_ASH1L |
- |
circASH1L |
gallbladder carcinoma |
ASH1L |
- |
S
| UP |
More |
| Human |
hsa_circ_ASH1L |
- |
circASH1L |
pancreatic adenocarcinoma |
ASH1L |
- |
S
| UP |
More |
| Human |
hsa_circ_ASH1L |
- |
circASH1L |
periampullary adenocarcinoma |
ASH1L |
- |
S
| UP |
More |
| Human |
hsa_circ_ASH1L |
- |
circASH1L |
colorectal cancer |
ASH1L |
- |
S
| UP |
More |
| Human |
hsa_circ_ASH1L |
hsa_circ_0003247 |
circASH1L(4,5) |
skin disorder |
ASH1L |
miR-129-5p |
Q
S
| UP |
More |
| Human |
hsa_circ_ASH1L |
hsa_circ_0000137 |
- |
cervical cancer |
ASH1L |
miR-1254 |
Q
M
| UP |
More |
| Human |
hsa_circ_ASH1L |
hsa_circ_0007608 |
- |
pulmonary hypertension |
ASH1L |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_ASH1L |
- |
circ-ASH1L |
systemic lupus erythematosus |
ASH1L |
- |
Q
S
| DN |
More |
| Human |
hsa_circ_ASH1L |
hsa_circ_0000137 |
circASH1L |
amyotrophic lateral sclerosis |
ASH1L |
- |
Q
| DS |
More |
| Human |
hsa_circ_ASH1L |
hsa_circ_0014592 |
circASH1L |
ovarian cancer |
ASH1L |
miR-515-5p |
Q
S
| UP |
More |
| Human |
hsa_circ_ASH1L |
hsa_circ_0003247 |
circASH1L / circASH1L-1 |
triple-negative breast carcinoma |
ASH1L |
- |
M
| UP |
More |